Skip to main content

Mesoporous TiO2 Nanoparticles Containing Ag Ion with Excellent Antimicrobial Activity at Remarkable Low Silver Concentrations

Buy Article:

$107.14 + tax (Refund Policy)

Mesoporous Ag–TiO2 nanoparticles with TiO2 homogenous anatase crystalline phase was synthesized using a one-pot sol–gel method. The sample was calcined at 100 °C and characterized by XRD, HR TEM, EDAX, IR spectroscopy, DRS, N2 adsorption–desorption isotherm and Brunauer–Emmett–Teller (BET) analysis. The BET surface area of the sample was 266 m2/g and the crystallite size as calculated using Scherrer formula was 3.76 nm. The Ag–TiO2 nanoparticles exhibited excellent antimicrobial activity against representative Gram-positive and Gram-negative bacterial cultures and Candida albicans. Complete inhibition of microorganisms was achieved at a very low Ag–TiO2 concentration, in the range of 1.0 to 20 μg/mL (effective Ag concentrations were 11.7 to 234 ppb) in less than 2 h under ambient conditions, without the requirement of photoactivation. Silver ion release studies showed that about 18% of silver ions were present in solution. Thus, it may be inferred that the antimicrobial activity is due to Ag ions released from the TiO2 matrix. The mesoporous nature and antimicrobial activity at low concentrations without photoactivation are important aspects which make this material an excellent candidate for potential application as disinfectant and/or antimicrobial agent.

Keywords: AG–TIO2; ANTIMICROBIAL; LOW TEMPERATURE; MESOPOROUS; SOL–GEL METHOD

Document Type: Research Article

Publication date: 01 April 2013

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content